Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$1.55B |
| 2 |
Comcast
CMCSA
|
+$449M |
| 3 |
SLB Ltd
SLB
|
+$298M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$281M |
| 5 |
Qualcomm
QCOM
|
+$228M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$229M |
| 2 |
Sempra
SRE
|
+$192M |
| 3 |
Bausch Health
BHC
|
+$183M |
| 4 |
BNY
Bank of New York Mellon
BNY
|
+$175M |
| 5 |
PepsiCo
PEP
|
+$173M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.58% |
| 2 | Energy | 11.62% |
| 3 | Consumer Discretionary | 8.89% |
| 4 | Financials | 8.63% |
| 5 | Technology | 8.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2426
Foster
FSTR
$401M
| $766K | ﹤0.01% |
62,410
+35,510
| +132% | +$791K |
|
|
RWT
2427
Redwood Trust
RWT
$593M
| $766K | ﹤0.01% |
+55,340
| New | +$832K |
|
|
PPBI
2428
DELISTED
Pacific Premier Bancorp
PPBI
| $764K | ﹤0.01% |
37,600
-19,202
| -34% | -$365K |
|
2429
CALL
Las Vegas Sands
LVS
$30.6B
| $759K | ﹤0.01% |
+20,000
| New | +$1.01M |
|
|
NJ
2430
DELISTED
NIDEC CP (NIHON KABUSHIKI KAISHA)1 ADS REPTG .25 SH COM STK
NJ
| $759K | ﹤0.01% |
43,795
+8,085
| +23% | +$160K |
|
|
CDTX
2431
DELISTED
Cidara Therapeutics
CDTX
| $757K | ﹤0.01% |
2,975
-2,895
| -49% | -$828K |
|
2432
iShares US Medical Devices ETF
IHI
$3.44B
| $757K | ﹤0.01% |
40,818
+27,048
| +196% | +$544K |
|
2433
Alerian MLP ETF
AMLP
$13.2B
| $755K | ﹤0.01% |
+12,100
| New | +$880K |
|
|
BWP
2434
CALL
DELISTED
Boardwalk Pipeline Partners
BWP
| $752K | ﹤0.01% |
63,900
-150,500
| -70% | -$2.05M |
|
2435
Avis
CAR
$5.13B
| $751K | ﹤0.01% |
17,200
-125,342
| -88% | -$5.44M |
|
|
PRSU
2436
Pursuit Attractions and Hospitality Inc
PRSU
$1.33B
| $749K | ﹤0.01% |
+25,838
| New | +$714K |
|
|
BPMC
2437
DELISTED
Blueprint Medicines
BPMC
| $747K | ﹤0.01% |
35,000
-45,200
| -56% | -$1.25M |
|
2438
Vulcan Materials
VMC
$35.5B
| $747K | ﹤0.01% |
8,375
-15,684
| -65% | -$1.46M |
|
|
CTIC
2439
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $747K | ﹤0.01% |
51,198
-60,573
| -54% | -$1.05M |
|
2440
iShares US Home Construction ETF
ITB
$2.29B
| $745K | ﹤0.01% |
+28,548
| New | +$794K |
|
2441
SPS Commerce
SPSC
$2.9B
| $745K | ﹤0.01% |
21,938
+1,370
| +7% | +$47.8K |
|
2442
Louisiana-Pacific
LPX
$5.06B
| $744K | ﹤0.01% |
52,250
-184,245
| -78% | -$2.92M |
|
2443
Power Integrations
POWI
$3.05B
| $742K | ﹤0.01% |
35,210
-35,660
| -50% | -$714K |
|
2444
Macerich
MAC
$6.88B
| $738K | ﹤0.01% |
9,613
-35,617
| -79% | -$2.76M |
|
|
CIVI
2445
DELISTED
Civitas Solutions, Inc.
CIVI
| $738K | ﹤0.01% |
32,207
-39,439
| -55% | -$942K |
|
2446
CoStar Group
CSGP
$13.3B
| $736K | ﹤0.01% |
42,520
+7,450
| +21% | +$143K |
|
2447
CALL
Cytokinetics
CYTK
$10.8B
| $736K | ﹤0.01% |
110,000
| – | – |
|
2448
Invesco S&P 500 Pure Value ETF
RPV
$1.74B
| $735K | ﹤0.01% |
15,385
+523
| +4% | +$26.8K |
|
|
OCLR
2449
DELISTED
Oclaro Inc.
OCLR
| $733K | ﹤0.01% |
318,667
-513,218
| -62% | -$1.26M |
|
|
ACSF
2450
DELISTED
American Capital Senior Floating, Ltd.
ACSF
| $728K | ﹤0.01% |
65,645
-3,681
| -5% | -$45.9K |
|
Similar funds
Israel Englander's Q3 2015 Portfolio in Review
As of Q3 2015, Israel Englander held 4,098 positions worth $51.6B, down 2.3% from $52.9B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Israel Englander deployed $5.12B of net new capital in Q3 2015, opening 839 new positions and adding to 1,320 existing holdings. Its largest new stake was BP: 4,551,492 shares worth $117M.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 15% a quarter earlier, followed by Energy and Consumer Discretionary.
On the sell side, the largest reduction was Alexion Pharmaceuticals, an estimated $229M trimmed.
- Israel Englander's largest Q3 2015 buy was BP: 4,551,492 shares worth $117M.
- Israel Englander added most to DuPont de Nemours in Q3 2015, an estimated $1.55B increase.
- Israel Englander's biggest Q3 2015 reduction was Alexion Pharmaceuticals, cutting an estimated $229M.
- Israel Englander fully exited PepsiCo in Q3 2015, selling an estimated $173M.
- Israel Englander's ten largest holdings make up 14% of its $51.6B portfolio in Q3 2015.
- Israel Englander opened 839 new positions and closed 681 in Q3 2015.
- Israel Englander's portfolio value fell 2.3% quarter-over-quarter to $51.6B.
Based on Millennium Management's 13F filing for Q3 2015, filed 16 Nov 2015.